Society for Immunotherapy of Cancer (SITC) shared a post on LinkedIn:
“Don’t miss the keynote at the 2026 EU Immuno-Oncology Drug Development Summit, on Sept. 3, 2026.
Join Dr. E. John Wherry as he examines how insights across immuno-oncology and autoimmune disease are shaping the next generation of therapeutic strategies.

Other articles featuring SITC on OncoDaily.